Total Reports
6
Low report volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for American Wirehair (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.
By recorded gender -- every report on file for American Wirehair, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, American Wirehair ranks #480 of 510 by total reports (6). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. American Wirehair has 6 reports now versus 6 in that prior snapshot: 0 the same number of (0.0%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to American Wirehair changesTotal Reports
6
Low report volume
Deaths Reported
0
of 6 reports
Death-coded share of reports
0.0%
0.0% death-coded
Avg Age at Report
5.6 yr
4.7 kg avg weight
0.0% of 6 american wirehair reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2013 | 1 | |
| 2016 | 1 | |
| 2018 | 1 | |
| 2020 | 1 | |
| 2024 | 1 | |
| 2025 | 1 | |
Signature read: 6 reports place American Wirehair in the lower third of breed filing volume (#480 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, American Wirehair sits at #480 of 510 by report volume among all breeds and #55 of 55 among cat breeds, with 6 reports and 0 (0.0%) death-coded. Mean age at report: 5.6 years, average weight 4.7 kg (10.4 lbs).
Top reported signs: Diarrhoea (2), Other abnormal test result NOS (2), Lethargy (see also Central nervous system depression in Neurological) (2). Most-referenced drug: Selamectin (3 reports), followed by Cefovecin (2) and Emodepside + Praziquantel (1).
Outcome coding on 6 status-recorded reports is dominated by Outcome Unknown (66.7%). Annual submissions ranged 1-2,025 across 6 years on file.
Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.
Sparse-volume peer sets for American Wirehair drawn from openFDA outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds by reported average weight (4.7 kg here).
What to do with this cat
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →